Q4 2024 Medirom Healthcare Technologies Inc Earnings Call Transcript
Key Points
- Total revenue increased by 21.5% due to higher sales of salons and outsourcing revenues.
- Net income rose by 20.1%, driven by gains from sales of loans and tax asset valuation allowances.
- Adjusted EBITDA improved to JPY2.7 million with a margin increase to 5%.
- Average revenue per customer grew by 3.9%, indicating enhanced customer engagement.
- Expansion in the digital preventive healthcare segment with the upgraded LAB application and Mother bracelet.
- Cost of revenue increased by 15.1% due to salon purchase-back transactions.
- SG&A expenses rose by 14.3%, attributed to higher professional fees and recruiting expenses.
- Impairment loss recorded due to expected salon closures in 2025.
- Increased reliance on short-term and long-term bank loans for financing activities.
- Potential risks associated with global expansion and franchising plans.
Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Medirom year end 2024 financial results and corporate update conference call. (Operator Instructions) A webcast replay of the call will be available beginning at 11:30 Eastern time today through June 4, 2025.
For dialing numbers and access codes to this replay, please refer to the company's webcast announcement of May 19 or earnings announcement of May 20. I would now like to turn the call over to Scott Powell, President of Skyline Corporate Communications Group, which is Medirom's investor relations firm. Please go ahead.
Good morning and thank you for participating in today's conference call. Joining me from Medirom's leadership team are Kouji Eguchi, Founder, President and CEO; and Fumitoshi Fujiwara, Director and Chief Financial Officer. During this call, Medirom management will be making forward-looking statements, including statements that address Medirom's expectations for future performance
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
